| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
This research services provides a current and future outlook for the evolving
biosimilars market in Europe. It includes an overview of the current situation
in Europe, various issues surrounding biosimilars, key drivers, restraints and
challenges facing market participants. In addition, it includes a segment-wise
and country-wise market opportunity analysis followed by recommendations to
market participants.
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
Executive Summary
2. GLOSSARY OF TERMS AND RESEARCH METHODOLOGY
Glossary of Terms
Research Methodology
3. EUROPEAN BIOSIMILARS MARKET
Introduction
- Definition
- Role of Biosimilars in the European Union
- Evolution of the Regulatory Pathway in the EU
- Key Issues Surrounding Biosimilars in the European Union
- Scope and Segmentation
- Market Overview
Market Engineering Research
- Market Engineering Measurements
- Industry Challenges
- Market Drivers
- Market Restraints
- Competitive Structure
4. COMPETITOR ANALYSIS
Key European Players
- Sandoz
- Bioceuticals
- BiogeneriX AG
- Biopartners GmbH
- Teva
Key Indian Players
- Dr. Reddy's Laboratories Limited
- Intas BioPharma
- Ranbaxy Laboratories Limited
- Reliance Life Sciences
- Wockhardt
5. COUNTRY-WISE OPPORTUNITY ANALYSIS
Analysis by Geography
- France
- Germany
- Italy
- Spain
- The United Kingdom
6. SEGMENT-WISE OPPORTUNITY ANALYSIS
Erythropoeitins
Granulocyte Colony Stimulating Factors
Human Growth Hormones
Insulin and Analogs
Interferons
7. STRATEGIC RECOMMENDATIONS
Key Success Factors
8. DATABASE OF KEY INDUSTRY PARTICIPANTS
Database of Market Participants
9. DECISION SUPPORT DATABASES
Key Databases
- Number of Biotech Companies
- Number of Patents Applied to the European Patent Office
- Government R&D Investment in Biotechnology
- Per cent Government Biotech R&D Investment
- Venture Capital Investment in Biotechnology
|
